AVENUE THERAPEUTICS INC - COM (ATXI)

CUSIP: 05360L304

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
75,846
Share change
+75,846
Total reported value
$765,000
Price per share
$10.10
Number of holders
10
Value change
+$765,000
Number of buys
10

Quarterly Holders Quick Answers

What is CUSIP 05360L304?
CUSIP 05360L304 identifies ATXI - AVENUE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVENUE THERAPEUTICS INC - COM (ATXI) as of Q3 2022

As of 30 Sep 2022, AVENUE THERAPEUTICS INC - COM (ATXI) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,846 shares. The largest 10 holders included CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP, TWO SIGMA SECURITIES, LLC, WELLS FARGO & COMPANY/MN, BlackRock Inc., MORGAN STANLEY, Tower Research Capital LLC (TRC), UBS Group AG, EMFO, LLC, and CITIGROUP INC. This page lists 10 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.